Allen Jim L. 4

What Happened

• Jim L. Allen, a director of BioCardia, was granted a derivative award for 8,000 shares on 2026-07-06. The filing lists an acquisition price of $0.00 (total reported cash = $0). The award is reported as a grant/award (transaction code A), not a sale or open-market purchase.

Key Details

• Transaction date: 2026-07-06; Filing date: 2026-07-07 (timely).
• Award: 8,000 derivative shares; reported acquisition price $0.00.
• Shares owned after transaction: not provided in the supplied data.
• Footnote: 100% of the shares vest and become exercisable on the one-year anniversary of the grant (i.e., 2027-07-06), contingent on Allen continuing as a service provider through that date.
• No 10b5-1 plan, tax-withholding, or late-filing flags noted in the provided information.

Context

• This is a compensation-style award that vests in one year; there is no immediate cash outlay or sale of shares. Derivative awards like this are commonly used for director compensation and do not by themselves indicate buying or selling intentions in the open market.